Demystifying Merck & Co: Insights From 8 Analyst Reviews
Demystifying Merck & Co: Insights From 8 Analyst Reviews
揭秘默沙東公司：來自8位分析師評論的見解
The perception...Across the recent three months, 8 analysts have shared their insights on Merck & Co (NYSE:MRK), expressing a variety of opinions spanning from bullish to bearish.
最近三個月來， 8位分析師就Merck & Co (紐交所:MRK) 發表了自己的見解，涵蓋了從看好到看淡的各種觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $144.12, a high estimate of $155.00, and a low estimate of $125.00. Observing a downward trend, the current average is 2.29% lower than the prior average price target of $147.50.
分析師通過對12個月的價格目標進行評估，提供更深入的見解，顯示出一個平均目標爲144.12美元，一個最高估值爲155.00美元，一個最低估值爲125.00美元。觀察到價格呈下降趨勢，當前平均目標比之前的147.50美元的平均價格目標低2.29%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
The perception...
通過...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。